SARS-CoV-2 Assay
AIT’s COVID-19 Coronavirus (SARS-CoV-2) PCR (Polymerase Chain Reaction) assay is specially designed, validated, and intended for medically indicated diagnostic testing in symptomatic patients. The assay's PCR probes (ThermoFisher 2019-nCoV Assay) target the SARS-CoV-2 replicase complex (ORF 1 ab), spike (S), and nucleocapsid (N) genes.
Availability: Commercially Available
Dr. John K. Granger
Medical Director
+1 940 383 2223
1500 IH 35W
Denton, TX 76207
USA
|
|
www.healthtrackrx.com
| Manufacturer |
| AIT Laboratories |
| Product Name |
| SARS-CoV-2 Assay |
| Detection Category |
| Biological |
| Detection Principle |
| Molecular; |
| Detection Method |
| Assays;Polymerase Chain Reaction; |
| Application |
| Diagnostics; |
| Equipment Type |
| Diagnostic |
| Product Synopsis |
| AIT’s COVID-19 Coronavirus (SARS-CoV-2) PCR (Polymerase Chain Reaction) assay is specially designed, validated, and intended for medically indicated diagnostic testing in symptomatic patients. The assay's PCR probes (ThermoFisher 2019-nCoV Assay) target the SARS-CoV-2 replicase complex (ORF 1 ab), spike (S), and nucleocapsid (N) genes. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| April 2020 |
| User Feedback Sources |
| Indifferent/No user feedback |
| No Information Is Available |
| Transportability |
| Handheld |
| Other Biological Targets |
| SARS-CoV-2 |
| Training Required |
| <1 day training |